Drug Trial Radar · NCT06656416
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Oct 2, 2024
Primary completion
Sep 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Alto NeuroscienceIndustry
- Sponsor type
- Industry
- First posted
- Oct 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II with current major depressive episode, when used adjunctively to a mood stabilizer and/or atypical antipsychotic, related to patient characteristics. Additionally, safety, tolerability, and efficacy will be assessed in a subsequent open label treatment period.
Conditions
- Bipolar Disorder I or II With a Major Depressive Episode
Interventions
ALTO-100Drug
ALTO-100 40 mg tablet BID
PlaceboDrug
Placebo tablet BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess efficacy of ALTO-100 versus placebo on depression symptoms in bipolar disorder in a pre-defined subgroup of participants as measured by the mean change from Day 1 to Week 6 on the Montgomery-Åsberg Depression Rating Scale (MADRS) total scoreTime frame: Change assessed from Day 1 to Week 6
Locations
68 sites in 2 countries. Site status is shown where the registry gives one.
Site 6074
Birmingham, Alabama · Withdrawn
Site 6036
Chandler, Arizona · Withdrawn
Site 6000
Phoenix, Arizona · Recruiting
Site 6087
Yuma, Arizona · Withdrawn
6039
Fayetteville, Arkansas · Withdrawn
6070
Little Rock, Arkansas · Terminated
Site 6133
Little Rock, Arkansas · Recruiting
Site 6153
Chino, California · Recruiting
Site 6081
Imperial, California · Withdrawn
6069
Los Angeles, California · Recruiting
Site 6016
Mather, California · Recruiting
Site 6082
Oceanside, California · Terminated
Site 6102
Riverside, California · Withdrawn
Site 6111
Sacramento, California · Recruiting
Site 6120
San Jose, California · Recruiting
Site 6112
Colorado Springs, Colorado · Recruiting
Site 6174
Jacksonville, Florida · Recruiting
Site 6067
Lauderhill, Florida · Withdrawn
Site 6123
Pinellas Park, Florida · Recruiting
Site 6015
Tampa, Florida · Recruiting
Site 6193
Atlanta, Georgia · Not yet recruiting
Site 6068
Atlanta, Georgia · Withdrawn
Site 6064
Peachtree Corners, Georgia · Recruiting
Site 6113
Chicago, Illinois · Recruiting
Site 6132
Carmel, Indiana · Recruiting
Site 6101
West Lafayette, Indiana · Terminated
Site 6151
Baltimore, Maryland · Withdrawn
Site 6076
Bel Air, Maryland · Recruiting
Site 6062
Gaithersburg, Maryland · Recruiting
Site 6182
Towson, Maryland · Recruiting
Site 6188
Worcester, Massachusetts · Recruiting
Site 6184
Ann Arbor, Michigan · Recruiting
Site 6155
Ann Arbor, Michigan · Recruiting
Site 6178
Grand Rapids, Michigan · Recruiting
Site 6122
Flowood, Mississippi · Recruiting
Site 6142
Lincoln, Nebraska · Withdrawn
Site 6144
Las Vegas, Nevada · Recruiting
Site 6104
Las Vegas, Nevada · Recruiting
Site 6066
Toms River, New Jersey · Recruiting
Site 6014
Albuquerque, New Mexico · Recruiting
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.